Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Goodwill & Intangibles (2016 - 2021)

Assembly Biosciences has reported Goodwill & Intangibles over the past 8 years, most recently at $41.6 million for Q3 2021.

  • For Q3 2021, Goodwill & Intangibles changed 0.0% year-over-year to $41.6 million; the TTM value through Sep 2021 reached $41.6 million, changed 0.0%, while the annual FY2020 figure was $41.6 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles for Q3 2021 was $41.6 million at Assembly Biosciences, roughly flat from $41.6 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $41.6 million in Q1 2017 and troughed at $41.6 million in Q4 2017.
  • A 5-year average of $41.6 million and a median of $41.6 million in 2017 define the central range for Goodwill & Intangibles.
  • On a YoY basis, Goodwill & Intangibles climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
  • Year by year, Goodwill & Intangibles stood at $41.6 million in 2017, then changed by 0.0% to $41.6 million in 2018, then changed by 0.0% to $41.6 million in 2019, then changed by 0.0% to $41.6 million in 2020, then changed by 0.0% to $41.6 million in 2021.
  • Business Quant data shows Goodwill & Intangibles for ASMB at $41.6 million in Q3 2021, $41.6 million in Q2 2021, and $41.6 million in Q1 2021.